Indianapolis, IN, United States of America

Steven Kovacevic


Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 99(Granted Patents)


Company Filing History:


Years Active: 1985-1998

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Mind of Steven Kovacevic

Introduction

Steven Kovacevic, an accomplished inventor based in Indianapolis, IN, has made significant contributions to the field of biotechnology. With an impressive portfolio of seven patents, his work primarily focuses on fusion proteins and DNA compounds that enhance various biological processes.

Latest Patents

One of his latest patents, titled "Fusion proteins comprising cell cycle regulatory proteins," provides innovative fusion proteins that include cyclins and cyclin-dependent kinases (CDKs). A preferred embodiment features the combination of human cyclin D1 and human CDK4, which are critical for cell cycle regulation. This invention includes modifications to improve purification, such as the addition of histidine residues for immobilized metal affinity chromatography, alongside antigenic determinants that aid in monoclonal antibody-based purification methods. Another notable patent relates to "Recombinant DNA expression vectors and DNA compounds that encode deacetoxycephalosporin C synthetase (DAOCS) activity." This invention encompasses DNA compounds suitable for constructing recombinant DNA expression vectors across various host cells, including E. coli and several fungal species.

Career Highlights

Steven Kovacevic currently works at Eli Lilly and Company, a global leader in the pharmaceutical industry. His innovative research efforts contribute to the development of new therapies and the advancement of biotechnological applications. His ability to bridge the gap between theoretical science and practical applications has made him a valuable asset in his field.

Collaborations

Throughout his career, Steven has collaborated with esteemed colleagues such as James R. Miller and Jeffrey T. Fayerman. These associations have further enhanced his research endeavors and contributed to the successful development of groundbreaking inventions.

Conclusion

Steven Kovacevic's work in the realm of fusion proteins and recombinant DNA technologies exemplifies the spirit of innovation. His contributions to Eli Lilly and Company and the broader biotechnological landscape reflect his dedication to advancing scientific knowledge and improving human health through innovative solutions. His portfolio of patents is a testament to his creativity and commitment to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…